In FIFA-Tied Corporate Campaign, Bristol Myers Squibb 'Won't Lose'

Why It Matters

Leveraging the World Cup’s global audience, BMS aims to amplify brand awareness and credibility among health‑care stakeholders and the public, reinforcing its image as a science‑driven, patient‑focused pharmaceutical leader.

Key Takeaways

• BMS’s largest campaign in six years aligns with FIFA World Cup
• Ads feature Ali Krieger, linking sports resilience to patient outcomes
• Target audiences include patients, policymakers, and key opinion leaders
• Microsite stays live a year after campaign, extending brand engagement

Pulse Analysis

The pharmaceutical industry has increasingly turned to high‑profile sporting events to cut through a crowded advertising landscape. By pairing medical breakthroughs with the emotional pull of soccer, companies can humanize complex therapies and reach audiences that might otherwise ignore traditional health messaging. The FIFA World Cup, with its billions of viewers, offers an unparalleled platform for brands seeking cultural relevance, especially as patients and policymakers alike respond to narratives of resilience and hope.

BMS’s "Won’t Lose" campaign exemplifies this strategy. The 30‑second spot, narrated by two‑time FIFA Women’s World Cup champion Ali Krieger, draws a parallel between the precision of science and the inches‑won games of soccer. Omnicom’s Siegel & Gale crafted a multi‑channel rollout that includes connected‑TV, programmatic display, streaming audio and social placements, each tailored to specific segments such as patients, policymakers and key opinion leaders. The campaign’s performance will be measured through reach, engagement, brand‑lift studies and microsite traffic, providing a data‑rich view of its impact on BMS’s reputation.

For the broader market, BMS’s approach signals a shift toward purpose‑driven, sport‑linked branding in pharma. By anchoring its message to a universally celebrated event, the company not only boosts immediate awareness but also positions itself as a partner in societal well‑being, a narrative that can influence prescribing habits and policy decisions. As the industry watches the campaign’s post‑World Cup metrics, the success of "Won’t Lose" could set a new benchmark for how drug makers leverage cultural moments to deepen stakeholder engagement.